Carbon Ion Radiotherapy in the Treatment of Pancreatic Cancer

Timothy D. Malouff(Mayo Clinic), Daniel M. Trifiletti(Mayo Clinic in Florida), Anita Mahajan(The University of Texas MD Anderson Cancer Center), Sunil Krishnan(Smith Family), Michael G. Haddock(Mayo Clinic in Arizona), Bradford S. Hoppe(Jacksonville College), Christopher L. Hallemeier(Mayo Clinic in Arizona), Chris Beltran(Mayo Clinic)

Pancreas

June 15, 2020

10.1097/mpa.0000000000001566

Cited by 10

Related Papers

Cholangiocarcinoma — evolving concepts and therapeutic strategies

|Nature Reviews Clinical Oncology|2017|1.7k

Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

|Journal of Clinical Oncology|2013|1.1k

Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer

|Annals of Surgery|2019|445

Clinical Features and Outcome in North American Adults With Moyamoya Phenomenon

|Stroke|2006|337

Phase I/II Trial of Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177

|Journal of Clinical Oncology|2008|275